Home
>
National Drug Code (NDC)
>
Increlex
Increlex - 15054-1040-5 - (mecasermin)
Drug Information of Increlex
| Product NDC: | 15054-1040 |
| Proprietary Name: | Increlex |
| Non Proprietary Name: | mecasermin |
| Active Ingredient(s): | 40 mg/4mL & nbsp; mecasermin |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Increlex
| Product NDC: | 15054-1040 |
| Labeler Name: | Ipsen Biopharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021839 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20060103 |
Package Information of Increlex
| Package NDC: | 15054-1040-5 |
| Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (15054-1040-5) > 4 mL in 1 VIAL, MULTI-DOSE |
NDC Information of Increlex
| NDC Code | 15054-1040-5 |
| Proprietary Name | Increlex |
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (15054-1040-5) > 4 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 15054-1040 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | mecasermin |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20060103 |
| Marketing Category Name | NDA |
| Labeler Name | Ipsen Biopharmaceuticals, Inc. |
| Substance Name | MECASERMIN |
| Strength Number | 40 |
| Strength Unit | mg/4mL |
| Pharmaceutical Classes |
